Similar articles for PMID: 21802393

Year	Number of Results
1991	1
1996	1
1998	2
2000	2
2002	2
2004	3
2005	2
2006	2
2007	3
2008	4
2009	2
2010	2
2011	5
2012	7
2013	8
2014	9
2015	7
2016	1
2018	1
2021	1
2024	0

1

Utility of a novel watch-based pulse detection system to detect pulselessness in human subjects.

Rickard J, Ahmed S, Baruch M, Klocman B, Martin DO, Menon V. Rickard J, et al. Heart Rhythm. 2011 Dec;8(12):1895-9. doi: 10.1016/j.hrthm.2011.07.030. Epub 2011 Jul 28. Heart Rhythm. 2011. PMID: 21802393 Clinical Trial.

2

Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).

Day JD, Doshi RN, Belott P, Birgersdotter-Green U, Behboodikhah M, Ott P, Glatter KA, Tobias S, Frumin H, Lee BK, Merillat J, Wiener I, Wang S, Grogin H, Chun S, Patrawalla R, Crandall B, Osborn JS, Weiss JP, Lappe DL, Neuman S. Day JD, et al. Circulation. 2007 May 8;115(18):2382-9. doi: 10.1161/CIRCULATIONAHA.106.663112. Epub 2007 Apr 30. Circulation. 2007. PMID: 17470697 Clinical Trial.

3

Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.

Baquero GA, Banchs JE, Depalma S, Young SK, Penny-Peterson ED, Samii SM, Wolbrette DL, Naccarelli GV, Gonzalez MD. Baquero GA, et al. J Cardiovasc Electrophysiol. 2012 Mar;23(3):296-301. doi: 10.1111/j.1540-8167.2011.02183.x. Epub 2011 Sep 28. J Cardiovasc Electrophysiol. 2012. PMID: 21955243

4

Defibrillation testing in everyday medical practice during implantable cardioverter defibrillator implantation in France: analysis from the LEADER registry.

Sadoul N, Defaye P, Mouton E, Bizeau O, Dupuis JM, Blangy H, Delarche N, Blanc JJ, Lazarus A; LEADER registry investigators. Sadoul N, et al. Arch Cardiovasc Dis. 2013 Nov;106(11):562-9. doi: 10.1016/j.acvd.2013.07.002. Epub 2013 Nov 4. Arch Cardiovasc Dis. 2013. PMID: 24200925 Free article.

5

Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.

Wilkoff BL, Williamson BD, Stern RS, Moore SL, Lu F, Lee SW, Birgersdotter-Green UM, Wathen MS, Van Gelder IC, Heubner BM, Brown ML, Holloman KK; PREPARE Study Investigators. Wilkoff BL, et al. J Am Coll Cardiol. 2008 Aug 12;52(7):541-50. doi: 10.1016/j.jacc.2008.05.011. J Am Coll Cardiol. 2008. PMID: 18687248 Free article. Clinical Trial.

6

Protection from outpatient sudden cardiac death following ICD removal using a wearable cardioverter defibrillator.

Tanawuttiwat T, Garisto JD, Salow A, Glad JM, Szymkiewicz S, Saltzman HE, Kutalek SP, Carrillo RG. Tanawuttiwat T, et al. Pacing Clin Electrophysiol. 2014 May;37(5):562-8. doi: 10.1111/pace.12319. Epub 2013 Dec 3. Pacing Clin Electrophysiol. 2014. PMID: 24762055

7

Defibrillation threshold testing: is it really necessary at the time of implantable cardioverter-defibrillator insertion?

Russo AM, Sauer W, Gerstenfeld EP, Hsia HH, Lin D, Cooper JM, Dixit S, Verdino RJ, Nayak HM, Callans DJ, Patel V, Marchlinski FE. Russo AM, et al. Heart Rhythm. 2005 May;2(5):456-61. doi: 10.1016/j.hrthm.2005.01.015. Heart Rhythm. 2005. PMID: 15840466

8

Heart failure and the risk of shocks in patients with implantable cardioverter defibrillators: results from the Triggers Of Ventricular Arrhythmias (TOVA) study.

Whang W, Mittleman MA, Rich DQ, Wang PJ, Ruskin JN, Tofler GH, Muller JE, Albert CM; TOVA Investigators. Whang W, et al. Circulation. 2004 Mar 23;109(11):1386-91. doi: 10.1161/01.CIR.0000120703.99433.1E. Epub 2004 Mar 1. Circulation. 2004. PMID: 14993132

9

Role of defibrillation threshold testing during implantable cardioverter-defibrillator placement: data from the Israeli ICD Registry.

Arnson Y, Suleiman M, Glikson M, Sela R, Geist M, Amit G, Schliamser JE, Goldenberg I, Ben-Zvi S, Orvin K, Rosenheck S, Adam Freedberg N, Strasberg B, Haim M. Arnson Y, et al. Heart Rhythm. 2014 May;11(5):814-21. doi: 10.1016/j.hrthm.2014.01.030. Epub 2014 Jan 30. Heart Rhythm. 2014. PMID: 24486799

10

Is defibrillation testing necessary for implantable transvenous defibrillators?: defibrillation testing is necessary at the time of implantable cardioverter defibrillator implantation.

Russo AM, Chung MK. Russo AM, et al. Circ Arrhythm Electrophysiol. 2014 Apr;7(2):337-46. doi: 10.1161/CIRCEP.113.000371. Circ Arrhythm Electrophysiol. 2014. PMID: 24736423 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

56 results

Results by year